| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 90549-84-1 | Glycine,N-[N-(N2-L-tyrosyl-D-arginyl)-L-phenylalanyl]-, ethyl ester (9CI); tyrosyl-arginyl-phenylalanyl-glycine ethyl ester |  | C28H39N7O6 | 詳情 | 供應(yīng)商 | |
| 64202-81-9 | Geldanamycin,17-amino-17-demethoxy-; 2-Azabicyclo[16.3.1]docosane,geldanamycin deriv.; 17-Amino-17-demethoxygeldanamycin; 17-Aminogeldanamycin; NSC 255109 |  | C28H39N3O8 | 詳情 | 供應(yīng)商 | |
| 2646-61-9 | L-Proline,N-[(phenylmethoxy)carbonyl]glycyl-L-prolyl-L-leucylglycyl- (9CI); L-Proline,1-[N-[N-[1-[N-[(phenylmethoxy)carbonyl]glycyl]-L-prolyl]-L-leucyl]glycyl]-; Proline, 1-[N-[N-[1-(N-carboxyglycyl)-L-prolyl]-L-leucyl]glycyl]-, N-benzylester (6CI); Proline, 1-[N-[N-[1-(N-carboxyglycyl)-L-prolyl]-L-leucyl]glycyl]-,N-benzyl ester, L- (7CI,8CI); N-(Benzyloxycarbonyl)glycyl-L-prolyl-L-leucylglycyl-L-proline; N-Carbobenzoxyglycyl-L-prolyl-L-leucylglycyl-L-proline |  | C28H39N5O8 | 詳情 | 供應(yīng)商 | |
| 117062-52-9 | L-Phenylalanine,N-[N-(N2-L-tyrosyl-D-arginyl)glycyl]-, ethyl ester (9CI); tyrosyl-arginyl-glycyl-phenylalanine ethyl ester |  | C28H39N7O6 | 詳情 | 供應(yīng)商 | |
| 133851-90-8 | L-Leucinamide,N-[[2-amino-3-(4-hydroxyphenyl)propoxy]acetyl]glycyl-L-phenylalanyl-, (S)-(9CI); enkephalinamide, Tyr(1)-psi-(methyleneoxy)-Gly(2)-Leu(5)- |  | C28H39N5O6 | 詳情 | 供應(yīng)商 | |
| 75829-10-6 | L-Phenylalaninamide,L-tyrosyl-D-alanylglycyl-N-(1-sulfopentyl)-, (R)- (9CI); enkephalin sulfonic acid, Ala(2)-Nle(5)- |  | C28H39N5O8S | 詳情 | 供應(yīng)商 | |
| 64260-40-8 | 1,4-Pentanediamine,N4-[5,8-dimethoxy-2-[[(phenylmethyl)thio]methyl]-6-quinolinyl]-N1,N1-diethyl- |  | C28H39N3O2S | 詳情 | 供應(yīng)商 | |
| 145131-62-0 | Urea,N-[2,6-bis(1-methylethyl)phenyl]-N'-[2-(1-methyl-1H-indol-3-yl)hexyl]-, (R)-(9CI) |  | C28H39N3O | 詳情 | 供應(yīng)商 | |
| 145131-38-0 | Urea,N-[2,6-bis(1-methylethyl)phenyl]-N'-[2-(1-methyl-1H-indol-3-yl)hexyl]- |  | C28H39N3O | 詳情 | 供應(yīng)商 | |
| 145131-63-1 | Urea,N-[2,6-bis(1-methylethyl)phenyl]-N'-[2-(1-methyl-1H-indol-3-yl)hexyl]-, (S)-(9CI); (+)-N(sup 1)-(2,6-Diisopropylphenyl)-N(sup 2)-(2-(1-methyl-3-indolyl)h exyl)urea |  | C28H39N3O | 詳情 | 供應(yīng)商 | |
| 145131-26-6 | Urea,N-[2,6-bis(1-methylethyl)phenyl]-N'-[2-ethyl-2-(1-methyl-1H-indol-3-yl)butyl]-; 3-(2,6-dipropan-2-ylphenyl)-1-[2-ethyl-2-(1-methylindol-3-yl)butyl]ure a |  | C28H39N3O | 詳情 | 供應(yīng)商 | |
| 154541-72-7 | 1H-Benzimidazole,2-[1-[2-[4-(1,1-dimethylethyl)phenyl]ethyl]-4-piperidinyl]-1-(2-ethoxyethyl)-; Alinastine |  | C28H39N3O | 詳情 | 供應(yīng)商 | |
| 5431-15-2 | 9-Phenanthrenemethanol,a-[5-(dibutylamino)pentyl]-,hydrochloride (1:1); 9-Phenanthrenemethanol,a-[5-(dibutylamino)pentyl]-,hydrochloride (9CI); NSC 13492 |  | C28H39NO.ClH | 詳情 | 供應(yīng)商 | |
| 36954-63-9 | 中文名稱暫缺 | N-ACETYLLACTOSAMINE HEPTAACETATE 98; N-ACETYLLACTOSAMINE HEPTAACETATE 98; N-Acetyl-D-lactosamineheptaacetate; N-Acetyllactosamine heptaacetate 98% | 無 | C28H39NO18 | 詳情 | 供應(yīng)商 |
| 100929-53-1 | DAGO ACETATE SALT; ala(2)-mephe(4)-gly(5)-enkephali; DAMGO ACETATE SALT; DAGO ACETATE SALT; [D-ALA2,N-ME-PHE4,GLY5-OL]-ENKEPHALIN ACETATE SALT; TYR-D-ALA-GLY-N-METHYL-PHE-GLY-OL ACETATE SALT; (D-ala2,N-me-phe4,gly5-ol)-enkephalin*acetate; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; (D-alanine2,N-methylphenylalanine4,glycine3-ol)enkephalin |  | C28H39N5O8 | 詳情 | 供應(yīng)商 | |
| 7675-65-2 | N-(2-硝基苯亞磺�；�)-S-苯甲基-L-半胱氨酸雙環(huán)己基銨鹽 | N-(2-NITROPHENYLSULFENYL)-S-BENZYL-L-CYSTEINE DICYCLOHEXYLAMMONIUM SALT; N-(2-NITROPHENYLTHIO)-S-BENZYL-L-CYSTEINE DICYCLOHEXYLAMMONIUM SALT; N-(2-NITROPHENYLSULFENYL)-S-BENZYL-L-CYSTEINE DICYCLOHEXYLAMMONIUM SALT; N-(2-NITROPHENYLSULFENYL)-S-BENZYL-L-CYSTEINE DICYCLOHEXYXLAMMONIUM SALT; O-NPS-S-BENZYL-L-CYSTEINE DICYCLOHEXYLAMINE SALT; N-NPS-S-BENZYL-L-CYSTEINE DICYCLOHEXYLAMMONIUM SALT; Nitrophenylsulfenylbenzylcysteinedicyclohexyxlammoniumsa; N-O-NITROPHENYLSULFENYL-S-BENZYL-L- CYST EINE, DI(CYCLOHEXYL)AMMONIUM; Nps-Cys(Bzl)-OH.DCHA |  | C28H39N3O4S2 | 詳情 | 供應(yīng)商 |
| 156727-74-1 | (+)-4-[(ΑR)-Α-((2S,5R)-4-烯丙基-2,5-二甲基-1-哌嗪基)-3-甲氧基芐基]-N,N-二乙基苯酰胺 | SNC 80; (+)-4-[(AR)-A-((2S,5R)-4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-METHOXYBENZYL]-N,N-DIETHYLBENZAM; (+)-4-[(AR)-A-((2S,5R)-4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-METHOXYBENZYL]-N,N-DIETHYLBENZAMIDE; (+)-4-[(AR)-ALPHA-((2S,5R)-4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-METHOXYBENZYL]-N,N-DIETHYLBENZAMIDE; SNC 80; (+)-4-[(αr)-α-((2s,5r)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-n,n-diethylbenzamide; 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide; (+)-4-[(aR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide; (+)-4-[(alphaR)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide |  | C28H39N3O2 | 詳情 | 供應(yīng)商 |
| 26090-29-9 | N-DIETHYLAMINOETHYL-P-[2-(-N-OCTYLOXY)-BENZOYL]AMINOBENZOATE |  | C28H39N2O4- | 詳情 | 供應(yīng)商 | |
| 755038-02-9 | 4-[[(7R)-8-環(huán)戊基-7-乙基-5,6,7,8-四氫-5-甲基-6-氧代-2-喋啶基]氨基]-3-甲氧基-N-(1-甲基-4-哌啶基)苯甲? | BI 2536; BI 2536; BI-2536, BoehringerPLK-1 inhibitor; 4-[[(7R)-8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide; Benzamide, 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-; Boehringer PLK-1 inhibitor; BI-2536(R-) |  | C28H39N7O3 | 詳情 | 供應(yīng)商 |
| 758679-97-9 | CID-2858522; CID-2858522; 1-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-(2-(3-hydroxypropylaMino)-5,6-diMethyl-1H-benzo[d]iMidazol-1-yl)ethanone; 1-[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]-ethanone |  | C28H39N3O3 | 詳情 | 供應(yīng)商 | |